Clicky

Omnimmune Holdings Inc(OMMH)

Description: Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.


Keywords: Biotechnology Immunology Antibodies Monoclonal Antibodies Cancer Treatment Vaccines Hormones Peptide Hormones Personalized Cancer Active Immunization Sex Hormones Human Chorionic Gonadotropin Passive Immunization

Home Page:

4600 Post Oak Place
Houston, TX 77027
United States
Phone: 713-622-8400


Officers

Name Title
Mr. Howard Becker Chief Operating Officer
Dr. Alexander Krichevsky D.V.M VP, Director of Research and Director

Exchange: OTCCE

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 5008.3826
IPO Date:
Fiscal Year End: December
Full Time Employees: 2
Back to stocks